Who is eligible for clinical trial NCT06945042?

Participants must meet protocol criteria for Acute Myeloid Leukemia. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06945042 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-07-21

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia (NCT06945042)

🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Wake Forest University Health Sciences

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by evaluating the impact of systematic financial navigation in addition to standard financial distress interventions during cancer treatment.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (5 items).

Location: Levine Cancer Insitute — Charlotte, North Carolina

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Ability to understand and willingness to sign an IRB-approved informed consent.
Age 18-64 years at the time of consent
Initial diagnosis of Acute Myeloid Leukemia (AML) per investigator Note: Date of initial diagnosis is the date of the bone marrow biopsy
Planned intensive induction chemotherapy Note: It is acceptable if chemotherapy has been initiated at the time of enrollment as long as it is within 30 days of therapy initiation
Ability to read and understand the English and/or Spanish language(s)
As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Diagnosis of Acute Promyelocytic Leukemia
Unwilling to receive induction chemotherapy for AML
Previous treatment for hematologic malignancy
Prior allogeneic hematopoietic stem cell transplant

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (2 Sites)

Levine Cancer Insitute — Charlotte, North Carolina
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗